文献速递消化内镜消化道肿瘤与早癌

内镜黏膜切除术后黏膜缺损边缘热消融的前瞻性国际多中心试验:1000例大型无蒂结直肠息肉结局

Outcomes of Thermal Ablation of the Mucosal Defect Margin After Endoscopic Mucosal Resection: A Prospective, International, Multicenter Trial of 1000 Large Nonpedunculated Colorectal Polyps.
PubMed 文献 · Gastroenterology · 2021-03-31

该前瞻性国际多中心试验纳入1049例大型(≥20 mm)无蒂结直肠息肉(LNPCP)患者,评估内镜黏膜切除术后缺损边缘热消融(EMR-T)在真实世界中的有效性。主要终点为首次监测结肠镜(SC1)时残留或复发腺瘤(RRA)的频率。结果显示,在完成完整EMR-T的LNPCP中,SC1时RRA频率为1.4%(10/707)。结论认为EMR-T简单、廉价且高效,应普遍用于EMR后LNPCP的管理。

要点

  • EMR-T在真实临床实践中可行,完整消融率达95.4%。
  • 完整EMR-T后首次监测结肠镜RRA频率仅1.4%。
  • EMR-T应普遍用于大型无蒂结直肠息肉EMR后管理。

核心结论

  • 在临床实践中,EMR-T是一种简单、廉价且高效的辅助技术,可能显著减少首次监测时的RRA。
  • EMR-T应普遍用于EMR后LNPCP的管理。

研究设计与样本

  • 国际多中心前瞻性试验(NCT02957058),纳入1049例LNPCP患者(1049个息肉),中位大小35 mm(IQR 25-45 mm),右半结肠占53.5%。
  • 排除累及回盲瓣、阑尾开口及环周生长的LNPCP。
  • 主要终点为首次监测结肠镜(SC1)时RRA的频率。

主要发现

  • 研究历时51个月(2016年5月至2020年8月),共纳入1049个LNPCP。
  • EMR-T的均匀完整性在989个LNPCP中实现(95.4%)。
  • 755/803(94.0%)符合条件LNPCP接受了SC1(中位时间6个月,IQR 5-7个月)。
  • 在完成完整EMR-T的LNPCP中,SC1时RRA频率为1.4%(10/707)。

临床怎么用

  • 对于大型(≥20 mm)无蒂结直肠息肉,EMR后应对缺损边缘行热消融(EMR-T)。
  • EMR-T可作为降低首次监测结肠镜时RRA的常规辅助手段。

局限性

  • 排除累及回盲瓣、阑尾开口及环周生长的LNPCP,结果可能不适用于这些病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Thermal ablation of the defect margin after endoscopic mucosal resection (EMR-T) for treating large (≥20 mm) nonpedunculated colorectal polyps (LNPCPs) has shown efficacy in a randomized trial, with a 4-fold reduction, in residual or recurrent adenoma (RRA) at first surveillance colonoscopy (SC1). The clinical effectiveness of this treatment, in the real world, remains unknown. METHODS: We sought to evaluate the effectiveness of EMR-T in an international multicenter prospective trial (NCT02957058). The primary endpoint was the frequency of RRA at SC1. Detailed demographic, procedural, and outcome data were recorded. Exclusion criteria were LNPCPs involving the ileo-caecal valve, the appendiceal orifice, and circumferential LNPCPs. RESULTS: During 51 months (May 2016-August 2020) 1049 LNPCPs in 1049 patients (median size, 35 mm; interquartile range, 25-45 mm; right colon location, 53.5%) were enrolled. Uniform completeness of EMR-T was achieved in 989 LNPCPs (95.4%). In this study, 755/803 (94.0%) eligible LNPCPs underwent SC1 (median time to SC1, 6 months; interquartile range, 5-7 months). For LNPCPs that underwent complete EMR-T, the frequency of RRA at SC1 was 1.4% (10/707). CONCLUSIONS: In clinical practice, EMR-T is a simple, inexpensive, and highly effective auxiliary technique that is likely to significantly reduce RRA at first surveillance. It should be universally used for the management of LNPCPs after EMR. https://clinicaltrials.gov; Clinical Trial Number, NCT02957058.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Sidhu M, Shahidi N, Gupta S, et al. Outcomes of Thermal Ablation of the Mucosal Defect Margin After Endoscopic Mucosal Resection: A Prospective, International, Multicenter Trial of 1000 Large Nonpedunculated Colorectal Polyps. Gastroenterology. 2021. PMID: 33798525. doi:10.1053/j.gastro.2021.03.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。